PMEL and neoplasm: Expression levels of many proteins were altered with resistance development including gp100/PMEL, CD171/L1CAM, GAB2, mTOR and PI3K-p85 which have been previously shown to be upregulated in tumors including CMM and promoting tumor progression24–28 (Fig. 5c, Supplementary Fig. S8b).